MoneyWorks4Me

Marksans Pharma informs about disclosure

22 Aug 2023 Evaluate

Pursuant to Regulation 7(2) of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, Marksans Pharma has informed that it enclosed disclosure in Form C made by Arvind Singh, an employee of the Company with respect to his sale of equity shares of the company.

The above information is a part of company’s filings submitted to BSE. 
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..